VEGFA and Retinal atrophy: The CATT study group reported that eyes with RAP were less likely to have fluid at 1 and 2 years after initiation of anti-VEGF therapy, but were also more likely to develop retinal atrophy.29 Multiple reports describe intraretinal cystoid changes with fluid as a characteristic optical coherence tomography feature of RAP lesions.30 31 Moreover, thinner choroid also increased the chance of achieving ER.